TIS tissue therapies limited

ema agenda

  1. 894 Posts.
    Well Vitrogro is not on the EMA's meeting agenda for discussion this month. Looks like we will have to wait until 23 June to see whether TIS have managed to assemble their response(s) for next months meeting. No news on the Company's progress regarding the CE Mark submission since 26 Feb, nigh on three months already. So if TIS actually submit the required data next month we would have experienced 120 days of EMA review and 120 days of TIS data collection, and reconvene on day 121 of the EMA review.

    There is a small window to get the data to the EMA otherwise four months will quickly turn into five months. Sorry but it does make a mockery of the 210 days timetable.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.